NMR News Alert Nomura Holdings Inc ADR (NMR) 5.66 02/14/2015

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Nomura Holdings Inc ADR (NMR) 5.66 $NMR

Updates on Asset Investment Banking and Brokerage Stocks - FXCM Inc., TD Ameritrade Holding, RCS Capital, BGC Partners, and Nomura Holdings
PR Newswire - Tue Feb 10, 7:55AM CST
Editor Note: For more information about this release, please scroll to bottom.
RCAP: 10.28 (+0.28), NMR: 5.66 (+0.11), FXCM: 2.21 (-0.01), AMTD: 35.84 (-0.22), BGCP: 9.34 (+0.19)

Report: Nomura teaming with TPG in bid for GE Capital portfolio
Seeking Alpha - at Seeking Alpha - Mon Feb 02, 2:34PM CST

GE: 25.15 (+0.26), NMR: 5.66 (+0.11)

Nomura Holdings' (NMR) Q3 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Sat Jan 31, 9:11PM CST

NMR: 5.66 (+0.11)

Nomura Holdings reports FQ3 profit
Seeking Alpha - at Seeking Alpha - Thu Jan 29, 8:41AM CST

NMR: 5.66 (+0.11)

Will Nomura see FHFA in court?
Seeking Alpha - at Seeking Alpha - Wed Jan 28, 3:55PM CST

NMR: 5.66 (+0.11)

Nomura looks to boost M&A business
Seeking Alpha - at Seeking Alpha - Wed Jan 21, 5:34AM CST

NMR: 5.66 (+0.11)

7 Stocks With The Longest Dividend Growth History
Dividend Yield - at Seeking Alpha - Mon Jan 05, 7:52PM CST
Many investors love dividend growth but there are only a dozen stocks with a dividend history over 50 consecutive years. Those stocks are called " Dividend Kings ." Today I'd like to highlight stocks that could hit a new record this year...
MMM: 165.94 (+0.03), PH: 124.06 (+2.23), GPC: 97.01 (+0.22), EMR: 58.68 (+0.08), DOV: 74.41 (+1.13), NMR: 5.66 (+0.11), PG: 85.90 (-0.13)

Nomura's European boss exits after just 18 months
Seeking Alpha - at Seeking Alpha - Wed Nov 19, 6:27AM CST

NMR: 5.66 (+0.11)

Nomura Holdings (NMR) Upgraded From Sell to Hold
at The Street - Fri Oct 31, 8:39AM CDT
Nomura Holdings NMR has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C.
NMR: 5.66 (+0.11)

Nomura Holdings
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Current Market Sentiment on HealthEquity Shares: A Closer Look

Updated Category News Views 113

Understanding HealthEquity's Short Interest Dynamics HealthEquity Inc (NYSE: HQY) has seen a significant decrease in its short percent of float, which recently dropped by 11.68%. As of the last report, the company had approximately 5.26 million shares sold short, representing 7.03% of its regular shares available for trading. This situation also highlights an average...

Continue Reading
Investors Update: Class Action Against Bumble Inc. Soon

Updated Category News Views 104

Update on Class Action Lawsuit Against Bumble Inc. (BMBL) The Law Offices of Frank R. Cruz are reminding investors about an upcoming significant deadline concerning a class action lawsuit against Bumble Inc. This lawsuit affects investors who acquired BMBL securities during the designated Class Period. Understanding the Class Action Lawsuit The class action was initiated...

Continue Reading
Analysis of Williams-Sonoma's Recent Surge and Current Changes

Updated Category News Views 293

Understanding Williams-Sonoma's Recent Stock Movements This week has seen an impressive rise of nearly 30% in shares of Williams-Sonoma, Inc. (NYSE: WSM), but recent trading indicates a slight pullback. Investors are reacting to two key factors: the natural tendency to take profits and the decision of some buyers to exit losing positions as market conditions evolve. The...

Continue Reading
Understanding the Arconic Corporation Class Action Update

Updated Category News Views 139

Overview of the Class Action Lawsuit Against Arconic Corporation Levi & Korsinsky, LLP has recently announced a class action regarding Arconic Corporation (ARNC). This situation affects investors who may have been impacted by alleged securities fraud. The firm aims to represent those who traded Arconic shares during a specified period and seeks to recover losses resulting...

Continue Reading
Cambrex Partners with Lilly to Enhance Biotech Innovations

Updated Category News Views 220

Cambrex's Strategic Collaboration with Eli Lilly Cambrex, a key player in the global contract development and manufacturing organization (CDMO) sector, has announced an exciting new partnership with Eli Lilly and Company to enhance support for biotech collaborators. Through this agreement, Cambrex aims to provide accelerated access to essential clinical development...

Continue Reading